In addition, DSCC1 is also considered as a potential diagnostic and prognostic biomarker for breast carcinoma, and facilitates the progression of breast carcinoma by activating Wnt/β-catenin signaling and inhibiting p53 [19]. Here, TP53 is linked to breast carcinoma.